Don K. Hamlin

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

Oliver W. Press, Melissa C. Corcoran, Krishnan Subbiah et al. · Blood · 2001 · 149 citations · Full text

Medicine, Hematology, Oncology +14

Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease

Steven I. Park, Jaideep Shenoi, John M. Pagel et al. · Blood · 2010 · 73 citations · Full text

Medicine, Immunology, Oncology +15

Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.

Krishnan Subbiah, Don K. Hamlin, John M. Pagel et al. · PubMed · 2003 · 68 citations

Medicine, Oncology, Pharmacology +17

A Streptavidin−Biotin Binding System That Minimizes Blocking by Endogenous Biotin

Kevin J. Hamblett, Brian B. Kegley, Don K. Hamlin et al. · Bioconjugate Chemistry · 2002 · 57 citations

Medicine, Oncology, Radiation Oncology +14

Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas

John M. Pagel, Yukang Lin, Nathan Hedin et al. · Blood · 2006 · 47 citations · Full text

Pharmacy, Immunology, Oncology +17